[Federal Register: March 23, 1999 (Volume 64, Number 55)]
[Notices]               
[Page 14002]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23mr99-87]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C. as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Evaluation of Chemopreventive Agent by in Vitro Techniques.
    Date: March 29, 1999.
    Agenda: To review and evaluate contract proposals.
    Place: 6130 Executive Blvd. 6th Floor, Rockville, MD 20852.
    Contact Person: Wilna A. Woods, PHD, Deputy Chief, Special 
Review, Referral and Research Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, Rockville, MD 20852, (301) 496-7903.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 12, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-6955 Filed 3-22-99; 8:45 am]
BILLING CODE 4140-01-M